| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 09/04/2013 | CN102188386B Nimesulide sustained-release pellets and preparation method thereof |
| 09/04/2013 | CN102161688B Cholesterol-structure-fragment-containing biocompatible synthesis liposomes as well as preparation method and application thereof |
| 09/04/2013 | CN102093446B Doxorubicin liposome derivatives and preparation method thereof |
| 09/04/2013 | CN101721708B ED-71 preparation |
| 09/04/2013 | CN101633657B Preparation method of palonosetron and palonosetron hydrochloride and injection |
| 09/04/2013 | CN101466730B A process for the preparation of poly-alfa-glutamic acid andderivatives thereof |
| 09/04/2013 | CN101146517B Methods and systems for operating an aerosol generator |
| 09/03/2013 | US8524885 Hydrazido derivatives of hyaluronic acid |
| 09/03/2013 | US8524871 Modified gherlin peptides |
| 09/03/2013 | US8524785 Methods for using rebaudioside C as a flavor enhancer |
| 09/03/2013 | US8524783 Polymer micelles containing anthracylines for the treatment of cancer |
| 09/03/2013 | US8524773 Utilization of dialkylfumarates |
| 09/03/2013 | US8524696 Water-soluble compositions of bioactive lipophilic compounds |
| 09/03/2013 | US8524673 Pharmaceutical formulation |
| 09/03/2013 | US8524660 Polyalkylene polymer compounds and uses thereof |
| 09/03/2013 | US8524658 Lactoferrin and brain health and development in infants |
| 09/03/2013 | US8524460 PSCA: prostate stem cell antigen and uses thereof |
| 09/03/2013 | US8524368 Charge-dynamic polymers and delivery of anionic compounds |
| 09/03/2013 | US8524280 Methods for enhancing the release and absorption of water insoluble active agents |
| 09/03/2013 | US8524279 Atomizing nozzles include a liquid nozzle adapted to disperse a supply of liquid and a gas nozzle adapted to disperse a supply of gas; spray drying at a commercial plant scale. |
| 09/03/2013 | US8524273 Transdermal absorption preparation |
| 09/03/2013 | US8524269 Oral compositions comprising edible oils and vitamins and/or minerals and methods for making oral compositions |
| 09/03/2013 | US8524262 Amphiphilic high refractive index organopolysiloxanes |
| 09/03/2013 | US8524244 Targeted therapeutics based on engineered proteins that bind EGFR |
| 09/03/2013 | US8524213 Cohesive gel of hyaluronic acid or hylan crosslinked with divinyl sulfone characterized by percentage modification and ratio of crosslinks to pendant groups; use treating, osteoarthritis, preventing surgical adhesions, soft tissue augmentation, drug delivery systems |
| 09/03/2013 | CA2781379C Topical formulations for the prevention of sexually transmitted disease and methods of producing the same |
| 09/03/2013 | CA2707691C Sphingomyelin containing preparation |
| 09/03/2013 | CA2687172C Anti-norovirus agent and composition containing the same |
| 09/03/2013 | CA2612080C Immediate-release therapeutic systems for improved oral absorption of 7-[(e)-t-butyloxyiminomethyl] camptothecin |
| 09/03/2013 | CA2602379C Method of increasing drug oral bioavailability and compositions of less toxic orotate salts |
| 09/03/2013 | CA2548559C Intranasal compositions comprising granisetron and chitosan |
| 09/03/2013 | CA2530783C Drop pills prepared from excipients derived from natural sources |
| 09/03/2013 | CA2504963C Conjugates of tnf and a ligand of cd13 receptor in combination with interferon-gamma for treating cancer |
| 09/03/2013 | CA2245877C Hybrid proteins which form heterodimers |
| 09/01/2013 | CA2807712A1 Methods for treating cancer |
| 08/29/2013 | WO2013126799A1 Compositions and methods for ocular delivery of a therapeutic agent |
| 08/29/2013 | WO2013126697A1 Transdermal compositions and methods for treating stretch marks |
| 08/29/2013 | WO2013126694A1 Topical compositions comprising fipronil and permethrin and methods of use |
| 08/29/2013 | WO2013126690A1 Modified microbial toxin receptor for delivering agents into cells |
| 08/29/2013 | WO2013126552A1 Buprenorphine nanoparticle composition and methods thereof |
| 08/29/2013 | WO2013126205A1 Mixed monoamine reuptake inhibitor in a biodegradable polymer carrier |
| 08/29/2013 | WO2013126155A1 Ophthalmic compositions with alkoxylated natural waxes |
| 08/29/2013 | WO2013125730A2 Cationic graft-copolymer for drug delivery system |
| 08/29/2013 | WO2013124865A1 Drug delivery system for finasteride to prostate |
| 08/29/2013 | WO2013124855A1 Hydrogel system comprising spatially separated bioactive polypeptides |
| 08/29/2013 | WO2013124820A1 Composition comprising a retinoid and benzoyl peroxide |
| 08/29/2013 | WO2013124818A1 Taste masked dispersible tablets |
| 08/29/2013 | WO2013124774A1 Stable dosage forms of imatinib mesylate |
| 08/29/2013 | WO2013124654A1 Cucurbituril-based hydrogels |
| 08/29/2013 | WO2013124620A1 Method of making a hydrogel |
| 08/29/2013 | WO2013124415A1 Self-preserved oil dispersions comprising boric |
| 08/29/2013 | WO2013124068A1 Combinations of albumin-based drug delivery systems |
| 08/29/2013 | US20130226113 Uv stable transdermal therapeutic plaster with a uv absorbing adhesive layer separated from the drug matrix |
| 08/29/2013 | US20130225697 Tamper-resistant dosage form comprising pharmacologically active compound and anionic polymer |
| 08/29/2013 | US20130225695 Method for preparation of an excipient suitable for pharmaceutical use |
| 08/29/2013 | US20130225663 Lipid delivery formulations |
| 08/29/2013 | US20130225625 Tamper-resistant pharmaceutical dosage form comprising nonionic surfactant |
| 08/29/2013 | US20130225598 Stabilized Amorphous Forms of Imatinib Mesylate |
| 08/29/2013 | US20130225516 Topical compositions comprising fipronil and permethrin and methods of use |
| 08/29/2013 | US20130225499 Method for administering omega-conopeptide |
| 08/29/2013 | US20130225496 Albumin Variants |
| 08/29/2013 | US20130224316 Melt-Blended Protein Composition |
| 08/29/2013 | US20130224308 Gel comprising reactive oxidant release agent |
| 08/29/2013 | US20130224301 Solid pharmaceutical dispersions with enhanced bioavailability |
| 08/29/2013 | US20130224300 Compositions and methods thereof for oral administration of drugs |
| 08/29/2013 | US20130224289 Gastric retained gabapentin dosage form |
| 08/29/2013 | US20130224248 Formulation suitable for stabilizing proteins, which is free of mammalian excipients |
| 08/29/2013 | US20130224241 Multivalent Meningococcal Polysaccharide-Protein Conjugate Vaccine |
| 08/29/2013 | US20130224229 Novel Curcumin-Antibody Conjugates as Anti-Cancer Agents |
| 08/29/2013 | US20130224227 Novel conjugates of cc-1065 analogs and bifunctional linkers |
| 08/29/2013 | US20130224215 A B Cell Depleting Agent for the Treatment of Atherosclerosis |
| 08/29/2013 | US20130224206 Compositions and methods for stem cell delivery |
| 08/29/2013 | US20130224198 Recombinant human epo-fc fusion proteins with prolonged half-life and enhanced erythropoietic activity in vivo |
| 08/29/2013 | US20130224138 Lanolin substitute, production method thereof and applications of same |
| 08/29/2013 | US20130224123 Nanoparticulate compositions having lysozyme as a surface stabilizer |
| 08/29/2013 | CA2807707A1 Compositions and methods for treating cancer |
| 08/28/2013 | EP2630972A2 N-terminal polysialylation |
| 08/28/2013 | EP2630971A1 Combinations of albumin-based drug delivery systems |
| 08/28/2013 | EP2630960A1 Transdermal Delivery of Beneficial Substances Effected by a Hostile Biophysical Environment |
| 08/28/2013 | EP2630956A2 Sustained-release pellets containing tacrolimus as an active ingredient |
| 08/28/2013 | EP2630953A1 Liposome composition and process for production thereof |
| 08/28/2013 | EP2630952A1 Self-preserved oil dispersions comprising boric acid |
| 08/28/2013 | EP2629801A2 Synergistic effects between auristatin-based antibody drug conjugates and inhibitors of the pi3k-akt mtor pathway |
| 08/28/2013 | EP2629800A1 Composition for enteric hard capsules, and enteric hard capsule preparedusing the composition |
| 08/28/2013 | EP2629786A2 Compositions for drug administration |
| 08/28/2013 | EP2629780A2 Implantable polymer for bone and vascular lesions |
| 08/28/2013 | EP2629779A2 Use of storage stable viscous phospholipid depot to treat wounds |
| 08/28/2013 | EP2629775A1 Sustained-release formulation for injection |
| 08/28/2013 | EP2629762A1 Pendant hydrophile bearing biodegradable compositions and related devices |
| 08/28/2013 | EP2629760A2 Therapeutic nanoparticles with high molecular weight copolymers |
| 08/28/2013 | EP2629758A2 Metal ion nanoclusters |
| 08/28/2013 | EP2629757A2 Brimonidine gel compositions and methods of use |
| 08/28/2013 | EP2629756A1 Pharmaceutical topical composition of mupirocin |
| 08/28/2013 | EP2629754A1 Liquid pharmaceutical composition for the delivery of active ingredients |
| 08/28/2013 | CN1955280B Potency regeneration cell and culturing method thereof |
| 08/28/2013 | CN103270049A Spider silk fusion protein structures for binding to an organic target |
| 08/28/2013 | CN103270040A High-efficiency catalysts, preparation and use thereof |
| 08/28/2013 | CN103269723A Materials and methods for conjugating a water soluble fatty acid derivative to a protein |
| 08/28/2013 | CN103269722A Aptamer conjugates for targeting of therapeutic and/or diagnostic nanocarriers |
| 08/28/2013 | CN103269721A Pretargeting kit, method and agents used therein |